The Production and Manufacturing team at ABL Europe is responsible for the large-scale production and processing of GMP viral vectors. This team oversees the entire manufacturing process, from upstream to downstream operations, ensuring compliance with regulatory standards and maintaining high-quality output. With a focus on efficiency and innovation, they support clients in the development of cutting-edge immunotherapy solutions, playing a crucial role in advancing clinical trials and licensure of gene therapy and vaccine products.